While other studies have demonstrated the potential roles of CD38+ tumor-associated macrophages in the clinical outcome of HCC patients (12, 13), the role of CD38 in tumor-infiltrating T cells in the HCC TME remains to be further elucidated. Here, CD38 is linked to hepatocellular carcinoma.